Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE

MONDAY, Aug. 21, 2023 -- For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news